Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» fispemifene
fispemifene
Apricus shares are routed after testosterone drug fails to deliver clinical benefits
Fierce Biotech
Mon, 03/28/16 - 09:14 pm
Apricus Biosciences
testosterone
fispemifene